logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2011 or most recent year available

Part (iv) All hallucinogen outpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium01000100202
Bulgaria00000100101
Czech Republic00000000000
Denmark02200000404
Germany014281920153201190119
Estonia:::::::::::
Ireland101500000606
Greece01011000303
Spain1092123922369069
France182123171312101050105
Italy2016150800039039
Cyprus00000000000
Latvia31256111017017
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary02100210606
Malta::2::::::::
Netherlands0145100011011
Austria01010200404
Poland4:1:::::::::
Portugal500010000101
Romania00000000000
Slovenia:::::::::::
Slovakia00000000000
Finland00000000000
Sweden101120000404
United Kingdom62154205100462212115520552
Croatia:1:1:::::::
Turkey:::::::::::
Norway70172121014014
Total42163171841046132449570957
 

Notes:

: Indicates no data available.

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

(7) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-10 part(iii), part(iv)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

Page last updated: Friday, 26 April 2013